Amphetamines are dopamine (DA) transporter substrates that induce calcium-independent monoamine release. Exactly how this occurs has been controversial (Seiden et al., 1993) . In the exchange diffusion model, the DA transporter is postulated to have a mobile site that mediates the translocation of DA across the membrane. d-Amphetamine (AMPH) is thought to act by substituting for DA, driving the carrier to the internal face of the plasma membrane where the site binds cytoplasmic DA and then releases it on returning to the external face (Fischer and Cho, 1979) . Although monoamine uptake transporters have been sequenced (Amara and Kuhar, 1993; Giros and Caron, 1993) , it is not clear whether their putative structures define a channel or a carrier (Levi and Raiteri, 1993) . In the weak base model (Sulzer and Rayport, 1990; Sulzer et al., 1993) et al., 1987; Sulzer and Rayport, 1990; Rudnick and Wall, 1992) . This would increase the availability of transmitter for reverse transport without requiring a mobile site. In support of this model, weak bases and protonophores, which cause an AMPH-like release of DA from isolated vesicles (Sulzer and Rayport, 1990 ) but are not substrates for the uptake transporter, induce reverse transport in cultured DA neurons (Sulzer et al., 1993) . In addition, low-affinity binding of AMPH to the vesicular transporter (Gonzalez et al., 1993; Schuldiner et al., 1993) may block vesicular uptake and cause a redistribution of DA similar to that mediated by collapse of synaptic vesicle proton gradients. The inhibition of AMPH action by uptake blockers including cocaine and nomifensine (Fischer and Cho, 1979; Liang and Rutledge, 1982; Hurd and Ungerstedt, 1989) suggests that uptake of AMPH as a substrate is required. However, it is not clear whether AMPH uptake alone is sufficient or whether AMPH acts intracellularly to promote DA release. To differentiate between the plasma membrane and synaptic vesicles as the principal site of AMPH action, we have used identified DA neurons to ask whether injections of AMPH, which bypass the uptake transporter, cause DA release. Then to clarify the mode of action, we have used recently developed microelectrochemical techniques to measure AMPH-induced redistribution of DA across the vesicular and plasma membranes.
Finally, we have addressed the role of the plasma membrane transporter by monitoring DA release due to intracellular DA injection in real time.
Materials and Methods
GDC electrochemistry. The use of the Planorbis comeus giant dopamine cell (GDC) for electrochemical experiments has been described previously (Chien et al., 1990; Ewing et al., 1992) . Briefly, adult Planorbis comeus were obtained from NASCO (Fort Addison, WI) and dissected to reveal the left pedal ganglion, which was immersed in 10 ml of snail saline and desheathed to expose the GDC. Snail saline contained 39 mM NaCl, 1.3 mM KCI, 4.5 mM CaCIZ, 1.5 mM MgC&, 6.9 mM NaHCO,, pH 7.4. Intracellular injections of AMPH or DA were carried out with pulled glass capillaries (0.5 pm tips) and an Eppendorf model 5242 pressure-based microinjector. Injection volumes were calibrated by injection of aqueous solution into mineral oil under microscopic observation and calculation of the volume of the spherical droplet. For AMPH injections, a 2 pm carbon ring ultramicroelectrode touching the GDC membrane was held at a steady potential of 0.8 V and the oxidation current measured over time. For DA injection experiments, the carbon ring electrode was again placed immediately against the GDC. Staircase voltammetry (-0.2 to 0.8 V, 50 steps, 20 mV/step, 50 msec/step) was used throughout to monitor DA release; current was sampled from each plotted voltammogram at 0.8 V versus a sodiumsaturated calomel reference electrode and plotted with respect to time. Nomifensine was applied by bath perfusion. All experiments were conducted at room temperature.
Single cell capillary electrophoresis. To measure the vesicular DA pool, single GDCs from juvenile snails were drawn into 25 pm i.d. X 75 cm long capillaries (dlefirowicz and Ewing, 1990; Kristensen et al., 1994) . A 1 min iniection of moroholinoethanesulfonic acid buffer (pH 5.65; was timed to produce an obtimal differential lysis of the plasma but not vesicular membranes. The resulting cellular-components were then separated by electrophoretic mobility in a 25 kV field applied to the capillarv and detected using a carbon fiber electrode held at 0.8 V.
PCj2 ceil quanta1 analysis. PC12 cells were obtained from the American Tvoe Culture Collection (Rockville. MD) and maintained using established methods (Greene and Tischler, 1976) . The catecholamine present in these cultures consists mostly of dopamine (about 90%); the remainder is mostly norepinephrine (E. Pothos and D. Sulzer, unpublished observations). Recording media contained 150 mM NaCl, 4.2 mM KCI, 1 .O mM NaH,PO,, 11.2 mM glucose, 0.7 mM MgCl,, 2 mM CaCl,, 10 mM HEPES (pH 7.4). Amperometric detection of individual exocytic events were monitored with a 5 pm diameter carbon fiber electrode (Kelly and Wightman, 1986) using an EI-400 potentiostat (Ensman Instrumentation,Bloomington, IN) and recorded to disk (Gateway 2000 PC) with a LabMaster Interface (Scientific Solutions, Solon, OH). The working electrode was placed on'a target cell and gently pushed down against-the cell body (about 1 pm) with a piezo-micropositioner (PCS-750/1000. Burleigh Instruments, Fishers, NY). Micropipettes containing stimulants were ilaced 10 pm above the substrate and 150 pm away from the target cell by micropositioners (Mertzhauser, Germany). Chemical stimulants were delivered by 6 set pressure pulses from a microinjector (Picospritzer II, General Valve, Fairfield, NJ). The estimated total injection volume was 30 nl per injection. Stimulation was carried out with a mixture of 105 mM KC1 and 1 mM nicotine, as this was found to produce more exocytic events than elevated potassium or 1 mM nicotine applied separately.
The output from the potent&tat was digitized at 820 Hz and analvzed using a locallv written program (Chen et al., 1994) . In short, a noise threshold was set as a slope-of 1.4 times the average slope of the 60 Hz noise (18 consecutive 60 Hz peaks). Peaks were defined as beginning at the starting point of any four consecutive data points, with positive slopes greater than the noise threshold. The ends of the peaks were defined as either the first point of four consecutive data points with a positive slope immediately after a negative slope or the value of the starting point of the peak, whichever was higher. Only peaks with baseline width between 9 and 29 msec (about 99% of the peaks identified) were considered in order to eliminate very rapid current transients or rare wide peaks that could represent overlapping multiple events. The number of molecules oxidized at the electrode face was determined by the relation N = Q/nF, where Q is the charge of the peak, n was assumed to be 2 (for catecholamines), N is the number of moles and !F is Faraday's constant (96,485 coulombs per equivalent).
Results

Intracellular AMPH injection and DA release
The left pedal ganglion of the pond snail Planorbis corneus contains a single giant DA neuron (GDC) that closely resembles mammalian DA neurons in several ways (Osborne et al., 1975) . The GDC displays nomifensine-sensitive DA uptake, reserpinesensitive vesicular DA uptake, and metabolizes DA to dihydroxyphenylacetic acid (DOPAC). However, unlike mammalian DA neurons, the adult GDC is approximately 200 pm in diameter, facilitating single cell analysis; and, it lacks ascorbic acid (Barber and Kempter, 1986) , facilitating the unambiguous electrochemical detection of DA.
We measured DA release in real time with carbon fiber microelectrodes (Wightman et al., 1991) touching the extracellular face of the GDC membrane ( Fig. IA) . Injection of 8 pl of 100 mM d-AMPH into the GDC rapidly released DA (Fig. 1B) . Based on an estimated cytosolic volume of 8 nl, the injection resulted in an intracellular concentration of about 100 pM AMPH. Although AMPH is amphiphilic and may diffuse from B Figure 1 . Intracellular injection of AMPH promotes DA release. A, Single GDCs from adult Planorbis comeus were impaled with an AMPH containing pipette. Oxidation current was measured with a 2 pm carbon ring ultramicroelectrode touching the GDC membrane and held at a steady potential of 0.8 V. B, AMPH (8 pl of 100 mM) was injected intracellularly (arrow), thereby bypassing the uptake transporter, and the increase in extracellular DA measured. Similar levels of DA release were found in three replications of the experiment using DC amperometry. The small, slow baseline decrease during these experiments results from adsorption of electrode oxidation products to the electrode surface (Lau et al., 1991) . C, The shape of the voltammogram (-0.2 initial potential to 0.8 V final potential) taken at the peak current value 14 set postinjection (filled circles) closely matched the voltammogram for a DA standard (solid line). AMPH, which lacks hydroxyl groups, is not oxidized at these potentials. Calibration: i = 0.5 for the experiment and 3 1.5 for the standard. the cell, it also diffuses rapidly in aqueous medium and would reach nanomolar levels within milliseconds. Extracellular DA increased following the injection, reaching a maximum of 1.43 + 0.58 FM (mean + SEM, n = 3). The shape of a voltammogram taken at the peak current value closely matched the voltammogram of a DA standard (Fig. 1 C) .
Measurement of the vesicular DA pool
To examine the effects of AMPH on the vesicular pool directly, we measured vesicular DA by capillary electrophoresis of juvenile GDCs (75 pm in diameter) (Kristensen et al., 1994) . Time-limited membrane lysis of single GDCs produces two distinct DA peaks (Fig. 2 , lower trace; cf. Kristensen et al., 1994) . Peak 1 is narrow and appears at the same time as a DA standard, indicating that it reflects free DA and DA from a readily releasable vesicular pool. Peak 2 appears later and is broader; furthermore, it is abolished by prior reserpine treatment or by more extensive lysis, indicating that it reflects a slower release of DA during electrophoresis from vesicles that have not undergone exocytosis. Thus, peak 2 provides a measure of vesicular DA principally in storage vesicles.
We found that prior treatment with AMPH (10 p,M for 15 min) reduced peak 2 to below detectable limits and correspondingly increased peak 1 (Fig. 2, upper Figure 2 . Electrophoretic separation of readily oxidized components from a single Phnorhis corneus giant DA neuron. Single neurons (75 p,rn diameter) from juvenile snails were drawn into capillary tubes. Subsequent injection of morpholinoethanesulfonic acid buffer (pH 5.65) for I min produced a partial lysis of the cell membranes, presumably mainly the plasma membrane. Based on this differential lysis, peak 1 reflects free DA and DA from easily released vesicles and peak 2 reflects vesicular DA (see text); peak 3 reflects other oxidizable compounds with a net neutral charge (Kristensen et al., 1994) . AMPH treatment increased peak 1 and reduced peak 2 to undetectable levels (see Table 1 ).
AMPH modulation of quanta1 size
To measure changes in the DA content of individual secretory vesicles, we monitored individual catecholamine release events (Wightman et al., 1991) in undifferentiated PC1 2 cells (Chen et al., 1994) , where release occurs from the cell body. Quanta1 packets were measured with a detection limit of 19,000 molecules. Since spontaneous release events in PC12 cells were rarely observed and undifferentiated PC12 cells do not produce action potentials, the cells were stimulated by local perfusion with nicotine and KC1 (Chen et al., 1994) . In each case, release events were measured for approximately 2 min following stimulation. In controls, individual exocytic events corresponded to the release of 11 1,000 ? 32,000 catecholamine molecules (n = 9 cells, 92 +-37 events per cell, mean ? SEM). AMPH (10 FM for 10 min) reduced stimulated catecholamine released per exocytic event. Randomly chosen amperograms for exocytosis from control cells and those treated with AMPH are shown in to IO FM AMPH for 15 min prior to sampling. The detection limit is typically l-10 amol. Figure 3 , A and B. When paired with age-matched controls from sister cultures (n = 3, 139 +-105 events per cell), the average exocytic event following incubation with AMPH (n = 7 cells, 34 + 9 events per cell) decreased to 48 2 5.4% of control (Fig.  3C) ; very few vesicles releasing > 200,000 molecules were present following AMPH.
DA release due to intracellular DA injection
To determine whether increased cytosolic DA is sufficient to induce release, we returned to the GDC. In the resting state, cytosolic DA is about 2.2 FM and extracellular DA below the limits of detection (Ewing et al., 1992) . Intracellular injection of 4 pl of 0.5 mM DA (Fig. 4A ) rapidly increased extracellular DA to.22.5 * 0.9 PM, 3.5 set postinjection (n = 3 cells); extracellular perfusion with nomifensine (a specific blocker of the DA uptake transporter that, unlike other commonly used uptake blockers, has no detectable effect on intracellular proton gradients; Sulzer et al., 1993) attenuated the increase in extracellular DA following subsequent injections by 87 ? 4%. After removal of nomifensine, the increase in extracellular DA due to intracellular DA injection returned to near control levels (20.4 ? 1.5 PM peak concentration, p = 0.265 by Student's t test, not significantly different). Intracellular injections of control solution lacking DA induced no DA release (data not shown). Difference voltammograms taken after the first, second, and fourth DA injections ( Fig. 4B ) closely resembled voltammograms of DA obtained by in vitro calibration.
Discussion
Whether AMPH acts principally at the plasma membrane uptake transporter or at the vesicular level has been controversial. We used two model systems to address this issue. Arguing for a principal mechanism of action at the vesicular level, intracellular injection of AMPH into the Planorbis GDC, which bypasses the plasma membrane uptake transporter, causes DA release. Wholecell capillary electrophoresis of GDCs shows that AMPH profoundly reduces vesicular DA; and amperometric detection of DA release in PC12 cells shows that AMPH significantly reduces DA release from individual exocytic events. Taken together, these results indicate that amphetamine redistributes DA from synaptic vesicles to the cytosol. Monitoring DA at the extracellular face of the GDC plasma membrane shows that intracellular injection of DA produces rapid nomifensine-sensitive release, indicating that increased cytosolic DA is sufficient to trigger reverse transport.
AMPH acts intracellularly
Injection of AMPH directly into the cytosol of the GDC causes DA release even though the uptake transporter is bypassed and the AMPH concentration gradient is in the opposite direction from that required for net efflux via exchange diffusion. Togeth- er with the uptake of AMPH by catecholamine transporters (Zaczek et al., 1991) , which would play a role in the specificity of transmitter release, and the ability of AMPH to release monoamines from isolated vesicles (Slotkin and Kirshner, 1971; Knepper et al., 1988; Sulzer and Rayport, 1990) , these observations argue for an intracellular site of AMPH action.
Consistent with redistribution of DA from vesicles to cytosol, capillary electrophoresis of single GDCs shows that AMPH redistributes DA from the putative vesicular DA pool. The redistribution of DA is greater than that from isolated vesicles (Sulzer and Rayport, 1990) perhaps because intracellular AMPH concentrations are increased due to specific uptake (Zaczek et al., 1991) . Moreover, the magnitude of the increase in free DA apparently exceeds the reduction in the vesicular peak. This could result either from blockade of DA metabolism due to AMPHmediated monoamine oxidase inhibition or from elevated DA synthesis. Alternatively, the disproportionate increase in free DA could be due to lysis of vesicles, leading to an underestimate of the vesicular pool and an overestimate of free DA. Nonetheless, the intact vesicular peak provides a measure of the major fraction of vesicular DA, and its profound reduction by AMPH favors an action of AMPH at the vesicular level. A number of reports on the effects of reserpine on AMPH-induced release (Parker and Cubeddu, 1986; Seiden et al., 1993; St. Remy et al., 1994) have been used to argue for and against models requiring AMPH action at the vesicular level. The present capillary electrophoresis results support a role for a vesicular pool in AMPHinduced DA release.
Furthermore, monitoring individual exocytic release events in undifferentiated PC12 cells, where vesicular release from the cell body can be measured, shows that AMPH reduces the transmitter content of individual vesicles. This occurs with 10 PM AMPH, a level reached in the brain with a standard dose (1 mg/ kg) (Melega et al., 1992) , and shows for the first time a reduction in quanta1 size (greater than 50%) due to a self-administered drug. In conjunction with the well-established role of AMPH in promoting stimulation-independent catecholamine release, these findings demonstrate that AMPH can attenuate stimulus-dependent release by reducing quanta1 size. These experiments do not, however, differentiate between collapse of the proton gradient (Sulzer and Rayport, 1990 ) and blockade of the vesicular amine transporter (Reith et al., 1993; Schuldiner et al., 1993) , which binds AMPH with low-affinity (Gonzalez et al., 1994) , and it may be that both effects play roles. Taken together, these experiments argue that AMPH principally redistributes DA from synaptic vesicles to the cytosol.
Alterations of the DA packaged in individual vesicles would be expected to profoundly affect synaptic transmission. Quanta1 analysis studies generally assume that the packaging of neurotransmitter per synaptic vesicle is invariant (Redman, 1990) . However, the present evidence, in conjunction with prior electrochemical results showing considerable variability in the size of release events (Wightman et al., 1991; Chow et al., 1992) , suggests that alterations of quanta1 size could play an important role in the modulation of neurotransmitter release.
Elevated cytosolic DA induces reverse transport
Injection of DA into the cytosol of GDCs leads to a rapid release of DA that is nomifensine sensitive. Uptake transport blockers like nomifensine are thought to block transport by binding to the extracellular face of the DA transporter; however, unlike AMPH, they are not transported (Anderson et al., 1989; Ritz et al., 1990) . We have previously shown in DA neuron cultures that nomifensine blocks DA release induced by AMPH, weak bases, and protonophores (Sulzer et al., 1993) The extent to which AMPH increases cytosolic DA will depend, in part, on the kinetics of reverse transport; since reverse transport due to DA is more rapid, increased AMPH-induced cytosolic DA levels are likely to be short lived.
The present experiments show transporter-mediated release from neurons in real time. This release can be induced solely by an increased transmitter concentration gradient without alteration of transmembrane ionic gradients. The release reaches physiologically significant levels since the extracellular DA measured in these experiments greatly exceeds the binding constants of DA receptors (O'Dowd et al., 1994) . Previously, reverse transport from retinal neurons was demonstrated using GABA uptake blocker-dependent currents in postsynaptic neurons (Schwartz, 1987) and in glial cells using voltage clamp techniques modeled to represent uptake-dependent potassium flux (Szatkowski et al., 1990) . More generally, reverse transport appears to be an important alternate form of neurotransmitter release (Levi and Raiteri, 1993) . Not only do uptake blockers attenuate calcium-independent release of radiolabeled monoamines (Lonart and Zigmond, 1991; McKenna et al., 1991) but they also attenuate release of GABA (Haycock et al., 1978; Pin and Bockaert, 1989; Bernath and Zigmond, 1990; Dunlop et al., 1991; O'Malley et al., 1992; Hitri et al., 1994) , and glutamate or aspartate (Dunlop et al., 1992; Turner et al., 1992) . Reverse transport of GABA appears to mediate signaling between retinal horizontal and cone cells (Schwartz, 1987) , reverse transport of glycine appears to modulate hippocampal NMDA receptors (Adam-Vizi, 1992; Attwell et al., 1993) , and reverse transport of glutamate during ischemia appears to be an important mode of release (Adam-Vizi, 1992; Attwell et al., 1993) . Our results now add a role for reverse transport in AMPH-induced DA release.
Conclusions
These findings demonstrate in invertebrate DA neurons and PC12 cells that AMPH decreases vesicular DA content, presumably resulting in DA redistribution to the cytosol. Cytosolic DA is, in turn, rapidly released by reverse transport. Since AMPHinduced DA release occurs independently of specific AMPH up-take by the plasma membrane transporter and can be induced in isolated monoamine vesicles (Slotkin and Kirshner, 197 1; Knepper et al., 1988; Sulzer and Rayport, 1990) , the present findings favor the release of DA from the vesicular pool. This mechanism has important implications for neurotransmission and pathology. It suggests that AMPH affects synaptic transmission both by increasing activity-independent reverse transport and by decreasing the amount of transmitter released during activity-dependent vesicular exocytosis. The result should be a reduction in the signal-to-noise ratio of stimulation-dependent monoamine synaptic transmission. Furthermore, this redistribution of DA from the relatively reducing environment of the synaptic vesicle to the cytosol appears to cause local increases in intracellular oxidative stress in DA neuron axons (Cubells et al., 1994) that may initiate AMPH neurotoxicity.
